NovaBridge Biosciences (NBP) EPS (Basic) (2019 - 2025)
NovaBridge Biosciences (NBP) reported EPS (Basic) of -$0.33 for Q4 2025, up 100.0% on a QoQ basis from -$85350.0 in Q3 2025.
NovaBridge Biosciences (NBP) has 5 years of EPS (Basic) data on file, last reported at -$0.33 in Q4 2025.
- Quarterly EPS (Basic) changed N/A year-over-year to -$0.33 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$352930.3 (down 216.38% YoY) and the FY2025 annual result came in at -$0.21, up 22.22% from the prior year.
- EPS (Basic) grew to -$0.33 in Q4 2025 per NBP's latest filing, from -$85350.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $343640.0 in Q2 2024 and bottomed at -$157500.0 in Q1 2025.
- The 3-year median for EPS (Basic) is -$1.42 (2023), against an average of -$4967.6.
- The widest annual swing landed in 2024, when EPS (Basic) surged 193902823.79%; it then sank 187.47% in 2025.
- Tracing NBP's EPS (Basic) over 3 years: stood at -$2.51 in 2023, then surged by 3894703.94% to $97576.2 in 2024, then plunged by 100.0% to -$0.33 in 2025.
- Per Business Quant, the three latest NBP EPS (Basic) figures stand at -$0.33 (Q4 2025), -$85350.0 (Q3 2025), and -$110080.0 (Q2 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | -85,350.00 |
| Jun 30, 2025 | -110,080.00 |
| Mar 31, 2025 | -157,500.00 |
| Sep 30, 2024 | 97,576.19 |
| Jun 30, 2024 | 343,640.00 |
| Mar 31, 2024 | -137,960.00 |
| Dec 31, 2023 | -2.51 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.18 |
| Dec 31, 2020 | 7.76 |
| Sep 30, 2020 | -5.38 |
| Dec 31, 2019 | -51.70 |